A Houston-based pharmaceuticals company filed for Chapter 7 bankruptcy, and its leaders have either resigned or been ...
The company said it will look to sell “substantially all of its assets” through a court-approved reorganization plan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback